Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase II Clinical Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00964626
What this trial is testing

Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Russian Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT02299635
What this trial is testing

A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

Who this might be right for
Triple Negative Breast Neoplasms
Pfizer 19
Testing effectiveness (Phase 2)Study completedNCT00534625
What this trial is testing

Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients

Who this might be right for
Asthma
Critical Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT00391989
What this trial is testing

Treatment of Adult Ph+ LAL With BMS-354825

Who this might be right for
Lymphoblastic Leukemia, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Testing effectiveness (Phase 2)Ended earlyNCT03367689
What this trial is testing

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent

Who this might be right for
Breast Cancer
MedSIR 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04821089
What this trial is testing

Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines
Ipsen 727
Testing effectiveness (Phase 2)Study completedNCT01643668
What this trial is testing

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00033618
What this trial is testing

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+31 more
National Cancer Institute (NCI) 144
Testing effectiveness (Phase 2)Study completedNCT01593410
What this trial is testing

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 194
Testing effectiveness (Phase 2)Ended earlyNCT04676360
What this trial is testing

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

Who this might be right for
Relapsed Plasmablastic LymphomaRefractory Plasmablastic LymphomaAnaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma
Jacob Soumerai, MD 10
Testing effectiveness (Phase 2)Looking for participantsNCT06007924
What this trial is testing

Avutometinib and Defactinib in People With Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00038623
What this trial is testing

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00093223
What this trial is testing

A Safety Study of ABI-007 for In-Stent Restenosis

Who this might be right for
Angina PectorisCoronary Artery Disease
Celgene 76
Testing effectiveness (Phase 2)Study completedNCT00826449
What this trial is testing

Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT02838238
What this trial is testing

X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00362115
What this trial is testing

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Takeda 449
Testing effectiveness (Phase 2)Study completedNCT01397708
What this trial is testing

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 26
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Testing effectiveness (Phase 2)Study completedNCT01152840
What this trial is testing

Study of RAD001 in Adenoid Cystic Carcinoma

Who this might be right for
Adenoid Cystic Carcinoma
Seoul National University Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT04863950
What this trial is testing

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
The University of Texas Health Science Center at San Antonio 25
Next Page